Ashish P. Sanghrajka

Mizuho Securities USA LLC is the US-based securities broker/dealer and futures commission merchant arm of Mizuho Americas LLC, ultimately held by Mizuho Financial Group, Inc. (TYO: 8411, NYSE: MFG) in Japan. Headquartered in New York City, the firm was founded in 1994 and provides institutional and corporate clients access to commodity and financial markets around the world. Mizuho Securities USA covers the following industries: Consumer, Energy, Financial Institutions, Financial Sponsors, Healthcare, Industrial & Diversified Industries, Power, Utilities & Infrastructure, Real Estate, and Technology, Media & Telecom (TMT). The firm and their affiliates hold memberships on all major futures and options exchanges worldwide.

Collins Stewart (CI) Ltd. is the Great Britain-based subsidiary of Canaccord Genuity Wealth (International) Ltd., itself a subsidiary of Canaccord Financial, Inc. (TSE: CF) in Canada. Founded in 1991, the firm provides stockbroking and investment management services from offices in Guernsey, Jersey and the Isle of Man to a range of customers including private clients, trusts, charities, pension funds and private companies.

BIO-IB, Inc. provides investment banking services.

DG2L Technologies Pvt Ltd. provides next-generation digital media technologies. It offers digital cinema systems and moving picture experts group for based next generation media solutions. The firm provides an integrated suite of encoding, authoring, distribution, and playback solutions for the delivery of interactive digital media over broadcast, broadband, and wireless networks to any devices. The company was founded by Tapesh Sinha and M. Asif M. H. Khan on July 14, 2003 and is headquartered in Mumbai, India.

Aestus Therapeutics, Inc. is a private company that operates as a therapeutics translational medicine company. The company is based in North Brunswick, NJ.

The Lung Cancer Research Foundation provides funding to cancer research centers. The firm offers treatment for small cell and non-small cell lung cancer. The company was founded by Laurie C. Carson in 2005 and is headquartered in New York, NY.